|
6VBD
Crystal structure of transpeptidase domain of PBP2 from Neisseria gonorrhoeae cephalosporin-resistant strain H041 acylated by ceftriaxone
提交 2019-12-18
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
237–575(339 aa)
|
未记录
|
CEF CEFOTAXIME, C3' cleaved, open, bound form × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 9.3;291 K;40% PEG 600, 0.1M CHES
|
分辨率 1.80 Å
R-free 0.195
|
|
8VBZ
Crystal structure of the transpeptidase domain of a S310A mutant of PBP2 from Neisseria gonorrhoeae strain H041
提交 2023-12-13
|
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
237–575(339 aa)
|
未记录
|
未记录非水小分子
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;291 K;32-40% PEG 600, 0.1 M CHES
|
分辨率 1.90 Å
R-free 0.211
|
|
8VEN
Crystal structure of transpeptidase domain of PBP2 from Neisseria gonorrhoeae cephalosporin-resistant strain H041 in complex with cefoperazone
提交 2023-12-20
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
237–575(339 aa)
|
未记录
|
A1ADP (2R,4R)-2-[(1R)-1-{[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}-2-oxoethyl]-5-methylidene-1,3-thiazinane-4-carboxylic acid × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;291 K;32-40% PEG 600, 0.1 M CHES
|
分辨率 1.80 Å
R-free 0.201
|
|
8VEP
Crystal structure of transpeptidase domain of PBP2 from Neisseria gonorrhoeae cephalosporin-resistant strain H041 acylated by piperacillin
提交 2023-12-20
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
237–575(339 aa)
|
未记录
|
JPP Piperacillin (Open Form) × 1
PEG DI(HYDROXYETHYL)ETHER × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 9.8;291 K;32-40% PEG 600, 0.1 M CHES
|
分辨率 2.00 Å
R-free 0.206
|
|
8VEQ
Crystal structure of transpeptidase domain of PBP2 from Neisseria gonorrhoeae cephalosporin-resistant strain H041 in complex with azlocillin
提交 2023-12-20
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
237–575(339 aa)
|
未记录
|
59H (2R,4S)-5,5-dimethyl-2-[(1R)-2-oxo-1-{[(2R)-2-{[(2-oxoimidazolidin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}ethyl]-1,3-thiazolidine-4-carboxylic acid × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 9.8;291 K;32-40% PEG 600, 0.1 M CHES
|
分辨率 2.40 Å
R-free 0.250
|
|
9OSK
Crystal structure of the transpeptidase domain of a Y422A mutant of PBP2 from Neisseria gonorrhoeae strain H041
提交 2025-05-24
|
突变/修饰不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
237–575(339 aa)
|
突变:Y422A
|
未记录非水小分子
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 2.60 Å
R-free 0.253
|
|
9OSL
Crystal structure of the transpeptidase domain of a Y422A mutant of PBP2 from Neisseria gonorrhoeae strain H041 acylated by ceftriaxone
提交 2025-05-24
|
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
237–575(339 aa)
|
未记录
|
未记录非水小分子
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 2.40 Å
R-free 0.243
|
|
9Z5T
Crystal structure of the transpeptidase domain of PBP2 from the Neisseria gonorrhoeae cephalosporin-resistant strain H041 in complex with boronate inhibitor VNRX-14079
提交 2025-11-12
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
237–575(339 aa)
|
未记录
|
A1C02 (3R)-7-fluoro-3-{[(2R)-2-(3-fluoro-4-phosphonophenyl)-2-{[3-(methanesulfonyl)-2-oxoimidazolidine-1-carbonyl]amino}acetyl]amino}-2-hydroxy-3,4-dihydro-2H-1,2-benzoxaborinine-8-carboxylic acid × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 9.3;291 K;40% PEG 600, 0.1 M CHES
|
分辨率 2.10 Å
R-free 0.236
|